Characteristics | Placebo | GIK | P value | ||
---|---|---|---|---|---|
(N = 54) | (N = 38) | ||||
Demographics | |||||
 Age, yearsa | 73.2 | (9.6) | 71.7 | (9.8) | 0.464b |
 Body Mass indexa | 29.5 | (6.1) | 27.7 | (4.5) | 0.128b |
 Sex, male | 33 | (61.1) | 20 | (52.6) | 0.418 |
Comorbidities | |||||
 Bernstein-Parsonnet scorea | 21.8 | (7.5) | 20.8 | (8.3) | 0.547b |
 Hypertension | 47 | (87.0) | 37 | (97.4) | 0.083 |
 Pulmonary Hypertension | 2 | (3.7) | 3 | (7.9) | 0.645c |
 Hypercholesterolemia | 37 | (68.5) | 29 | (76.3) | 0.413 |
 Diabetes mellitus | 17 | (31.5) | 13 | (34.2) | 0.783 |
 Vascular disease | 23 | (42.6) | 15 | (39.5) | 0.765 |
 Chronic Obstructive Lung Disease | 6 | (11.1) | 2 | (5.3) | 0.463c |
 Previous cardiac surgery | 3 | (5.6) | 1 | (2.6) | 0.640c |
Preoperative blood parameters | |||||
 Hemoglobin, g/dLa | 12.5 | (2.1) | 12.4 | (2.0) | 0.747b |
 Creatinine clearance, ml/min a | 81.1 | (34.6) | 75.4 | (30.0) | 0.418b |
Surgical data | |||||
 CPB time, mina | 97.1 | (37.5) | 102.2 | (47.8) | 0.564b |
 Aortic clamping time, mina | 74.3 | (29.0) | 76.5 | (32.0) | 0.730b |
Intraoperative fluids and blood | |||||
 Crystalloids and colloids, mla | 3′213 | (1214) | 2′897 | (850) | 0.170b |
 Blood transfusion | 31 | (57.4) | 26 | (68.4) | 0.284 |
 Fresh frozen plasma | 12 | (22.2) | 9 | (23.7) | 0.869 |
 Platelets | 8 | (14.8) | 4 | (10.5) | 0.362 |
Blood glucose (mMol/L) | |||||
 Start of surgerya | 6.7 | (1.5) | 6.7 | (1.6) | 0.980b |
 Before bypassa | 7.4 | (1.6) | 7.6 | (2.9) | 0.621b |
 During Bypassa | 7.4 | (1.7) | 7.1 | (2.5) | 0.556b |
 End of surgerya | 7.6 | (1.9) | 6.8 | (2.1) | 0.158b |